Simulations Operating Margin from 2010 to 2026

SLP Stock

USD 12.33 -0.14 -1.12%

Simulations Plus' Operating Profit Margin has experienced a moving downward cycle characterized by slightly volatile volatility. Compared with the previous period, Operating Profit Margin is up roughly 5.26%, supporting projections near -0.76.

Use the financial statements timeline for Simulations Plus to frame performance drivers and balance sheet structure. It connects Depreciation And Amortization of 9.9 M, Interest Expense of 0.0 or Total Revenue of 95.6 M and ratios such as Price To Sales Ratio of 5.9, Dividend Yield of 0.0072 or PTB Ratio of 2.49 with Simulations Plus Valuation and Volatility context.

Build AI portfolio with Simulations Stock

Use Simulations Plus Correlation to compare Simulations Plus against competitors. This provides competitive positioning context.

Our How to Invest in Simulations Plus guide provides practical guidance on trading Simulations Stock.

Evaluating Simulations Plus's Operating Margin across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Simulations Plus's fundamental strength.

Latest Simulations Plus' Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Simulations Plus over the last few years. It is Simulations Plus' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Simulations Plus' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0.04 %

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Profit Margin

Timeline

Simulations Operating Margin Regression Statistics

	Arithmetic Mean	0.10
	Coefficient Of Variation	433.38
	Mean Deviation	0.33
	Median	0.31
	Standard Deviation	0.45
	Sample Variance	0.20
	Range	1.2554
	R-Value	-0.76
	Mean Square Error	0.09
	R-Squared	0.58
	Significance	0.0004
	Slope	-0.07
	Total Sum of Squares	3.20

Simulations Operating Margin History

	2026	-0.76
	2025	-0.8
	2024	-0.89
	2023	0.0876
	2022	0.15
	2020	0.24
	2019	0.28

Stock Overview, Methodology & Data Sources

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California. Simulations Plus is traded on NASDAQ Exchange in the United States. This overview emphasizes how Simulations Plus compares to peers on valuation quality and operating consistency. Current metrics include P/E of 75.17, P/B of 1.98, profit margin of -81.66%. Simulations Plus has a market cap of 251.23 M, P/E of 75.17, ROE of -41.21%.

Methodology

Unless otherwise specified, financial data for Simulations Plus is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Simulations (USA Stocks:SLP) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Simulations Plus is covered by 7 analysts. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include RBC Capital Markets, Barclays, HSBC Global Research, Wells Fargo Securities, Bank of America Securities, Jefferies, Deutsche Bank, Stifel, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Pair Trading with Simulations Plus

Pair trading with Simulations Plus can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Moving together with Simulations Stock

0.82	GLH	Global Health	Pair Corr
0.92	DH	DeFinitive Healthcare	Pair Corr
0.77	VSEE	VSee Health	Pair Corr
0.83	EVH	Evolent Health	Pair Corr

Moving against Simulations Stock

0.38

CHS

Comprehensive Healthcare

Pair Corr

The effectiveness of tax-loss harvesting on Simulations Plus depends on finding a suitable replacement asset. Instruments with correlation above 0.9 to Simulations Plus typically provide adequate market exposure during the required holding period.

Interpreting the correlation table for Simulations Plus: readings above 0.8 indicate strongly correlated pairs with minimal diversification benefit, while readings between -0.2 and +0.2 around Simulations Plus suggest near-independence and genuine portfolio diversification value.

Use Correlation analysis and pair trading evaluation for Simulations Plus to review hedging context. The view can be extended across sectors or other related groups.

Pair Correlation Correlation Matching

Additional Tools for Simulations Stock Analysis

	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC